These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 12615720
21. Sufficiency of the CD8+ T cell lineage to mount an effective tumoricidal response to syngeneic tumor-bearing novel class I MHC antigens. Fan ST, Edgington TS. J Immunol; 1989 Dec 15; 143(12):4287-91. PubMed ID: 2531780 [Abstract] [Full Text] [Related]
22. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. Mylin LM, Schell TD, Roberts D, Epler M, Boesteanu A, Collins EJ, Frelinger JA, Joyce S, Tevethia SS. J Virol; 2000 Aug 15; 74(15):6922-34. PubMed ID: 10888631 [Abstract] [Full Text] [Related]
23. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H. Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645 [Abstract] [Full Text] [Related]
24. The role of CD4+ T cells in immunity to malaria sporozoites. Weiss WR, Sedegah M, Berzofsky JA, Hoffman SL. J Immunol; 1993 Sep 01; 151(5):2690-8. PubMed ID: 8103069 [Abstract] [Full Text] [Related]
25. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response. Flanagan K, Glover RT, Hörig H, Yang W, Kaufman HL. Vaccine; 2004 Jul 29; 22(21-22):2894-903. PubMed ID: 15246626 [Abstract] [Full Text] [Related]
26. Dendritic epidermal T cells in ultraviolet-irradiated skin enhance skin tumor growth by inhibiting CD4+ T-cell-mediated immunity. Cavanagh LL, Halliday GM. Cancer Res; 1996 Jun 01; 56(11):2607-15. PubMed ID: 8653705 [Abstract] [Full Text] [Related]
27. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory. Hao S, Yuan J, Xiang J. J Leukoc Biol; 2007 Oct 01; 82(4):829-38. PubMed ID: 17626150 [Abstract] [Full Text] [Related]
28. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo. Garcia Casado J, Janda J, Wei J, Chapatte L, Colombetti S, Alves P, Ritter G, Ayyoub M, Valmori D, Chen W, Lévy F. Eur J Immunol; 2008 Jul 01; 38(7):1867-76. PubMed ID: 18546142 [Abstract] [Full Text] [Related]
29. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762. Frey AB. J Immunol; 1996 May 15; 156(10):3841-9. PubMed ID: 8621922 [Abstract] [Full Text] [Related]
30. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer]. Chang XH, Cui H, Feng J, Yang WL, Li Y, Fu TY. Ai Zheng; 2004 Jul 15; 23(7):777-81. PubMed ID: 15248911 [Abstract] [Full Text] [Related]
31. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens. Cohen PA, Cohen PJ, Rosenberg SA, Mulé JJ. Cancer Res; 1994 Feb 15; 54(4):1055-8. PubMed ID: 7906197 [Abstract] [Full Text] [Related]
32. Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan. Mortara L, Balza E, Sassi F, Castellani P, Carnemolla B, De Lerma Barbaro A, Fossati S, Tosi G, Accolla RS, Borsi L. Eur J Immunol; 2007 Dec 15; 37(12):3381-92. PubMed ID: 18022863 [Abstract] [Full Text] [Related]
33. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene. Ebihara S, Endo S, Ito K, Ito Y, Akiyama K, Obinata M, Takai T. J Biochem; 2004 Sep 15; 136(3):321-8. PubMed ID: 15598888 [Abstract] [Full Text] [Related]
34. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy. Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K. Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722 [Abstract] [Full Text] [Related]
35. Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells. Moeller M, Kershaw MH, Cameron R, Westwood JA, Trapani JA, Smyth MJ, Darcy PK. Cancer Res; 2007 Dec 01; 67(23):11428-37. PubMed ID: 18056471 [Abstract] [Full Text] [Related]
36. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Rowe HM, Lopes L, Ikeda Y, Bailey R, Barde I, Zenke M, Chain BM, Collins MK. Mol Ther; 2006 Feb 01; 13(2):310-9. PubMed ID: 16275163 [Abstract] [Full Text] [Related]
37. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract. Bharhani MS, Grewal JS, Peppler R, Enockson C, London L, London SD. Int Immunol; 2007 Apr 01; 19(4):567-79. PubMed ID: 17369189 [Abstract] [Full Text] [Related]
38. Mutating the anchor residues associated with MHC binding inhibits and deviates CD8+ T cell mediated protective immunity against malaria. Dobaño C, McTague A, Sette A, Hoffman SL, Rogers WO, Doolan DL. Mol Immunol; 2007 Mar 01; 44(9):2235-48. PubMed ID: 17169429 [Abstract] [Full Text] [Related]
39. Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity. Claassen EA, van Bleek GM, Rychnavska ZS, de Groot RJ, Hensen EJ, Tijhaar EJ, van Eden W, van der Most RG. Virology; 2007 Nov 10; 368(1):17-25. PubMed ID: 17632195 [Abstract] [Full Text] [Related]
40. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma. Jassar AS, Suzuki E, Kapoor V, Sun J, Silverberg MB, Cheung L, Burdick MD, Strieter RM, Ching LM, Kaiser LR, Albelda SM. Cancer Res; 2005 Dec 15; 65(24):11752-61. PubMed ID: 16357188 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]